Practical Screening for Islet Autoantibodies: The Time Has Come.

Area of Science:

• Endocrinology
• Family Medicine
• Genetics

Background:

• Type 1 diabetes (T1D) prevalence is rising, increasing the likelihood of family physicians encountering first-degree relatives at genetic risk.
• These relatives may possess a genetic predisposition for developing T1D.

Purpose of the Study:

• To highlight the importance of T1D autoantibody screening by family clinicians.
• To identify individuals at high risk for T1D early.
• To underscore the short- and long-term health benefits of early detection.

Main Methods:

• Discussing the availability of multiple T1D screening options and programs for clinicians.
• Emphasizing comprehensive programs that include patient education, testing, result analysis, and follow-up.
• Mentioning the opportunity for participants to engage in T1D prevention trials.

Main Results:

• Family medicine clinicians are uniquely positioned to offer monitoring and follow-up.
• Positive autoantibody results in family members necessitate crucial provider-patient relationship support.
• Early screening facilitates timely intervention and management strategies.

Conclusions:

• T1D autoantibody screening by family physicians is a vital tool for early risk identification.
• Leveraging the provider-patient relationship in family medicine is key for effective monitoring and follow-up of at-risk individuals.
• Screening programs support proactive health management and potential participation in T1D prevention research.